Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium lactate + dextrose monohydrate + calcium chloride + sodium chloride + potassium chloride** is a sterile intravenous crystalloid combination solution corresponding to **Lactated Ringer's and 5% Dextrose Injection**. It provides water, electrolytes, lactate as a bicarbonate precursor, and dextrose as a carbohydrate calorie source. Clinically, it is used as a parenteral fluid, nutrient, and electrolyte replenisher for hydration and replacement of extracellular fluid losses in adults and pediatric patients, and can also function as an alkalinizing agent through metabolism of lactate to bicarbonate. This is an established hospital infusion product rather than a novel pipeline asset, with manufacturing and distribution reported for Fresenius Kabi and HP Halden Pharma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + dextrose monohydrate + calcium chloride + sodium chloride + potassium chloride.